Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency - Archive ouverte HAL Access content directly
Journal Articles Pharmacogenomics Year : 2019

Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency

Not file

Dates and versions

hal-02483216 , version 1 (18-02-2020)

Identifiers

Cite

Crescent Gbeto, Sylvie Quaranta, Roxane Mari, Raphaelle Fanciullino, Catherine Roche, et al.. Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency. Pharmacogenomics, 2019, 20 (13), pp.931-938. ⟨10.2217/pgs-2019-0028⟩. ⟨hal-02483216⟩
45 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More